Effect of Intrapulpal Injections on the Post-endodontic Pain
1 other identifier
interventional
108
1 country
1
Brief Summary
To achieve painless treatment in patients with a failed primary IANB, supplementary anesthesia has been advised. The majority of the studies evaluating intrapulpal injections have been performed on asymptomatic teeth. Very limited research has been dedicated to the evaluation of different variables in intrapulpal injections in patients with symptomatic irreversible pulpitis. The aim of this study was to evaluate postoperative pain after an intrapulpal anesthesia injection given after a failed inferior alveolar nerve block (IANB), in patients with symptomatic irreversible pulpitis. This prospective, randomized, double-blind clinical trial was carried out at the Department of Conservative Dentistry and Endodontics, Faculty of Dentistry, Jamia Millia Islamia. One hundred and eight adult patients, with symptomatic irreversible pulpits in a mandibular first or second molar received an initial IANB with 2% lidocaine. Pain during the endodontic treatment was assessed using a visual analog scale (VAS). Patients experiencing pain on endodontic intervention were randomly allocated to one of the two treatment groups: one group received a supplementary intrapulpal injection while the other received a supplementary intraligamentary injection The presence of postoperative pain was assessed at 1, 2, 3, and 7 days after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2023
CompletedFirst Submitted
Initial submission to the registry
October 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
October 18, 2023
CompletedOctober 19, 2023
October 1, 2023
3 months
October 3, 2023
October 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Post-endodontic pain using a visual analouge scale (VAS)
Evaluation of numerical visual analouge pain scores after the completion of root canal treatment. The scale was 170mm long and the the values were continous and numerical. The 0 indicates no pain and 170 indicates the maximum possible pain
6hours, 1 day, 3 days, 7 days
Study Arms (2)
Supplementary Intrapulpal injection
ACTIVE COMPARATORSupplementary Intrapulpal injections were given using a 30-gauze needle with sufficient back pressure.
Intraligamentary injection
ACTIVE COMPARATORIntraligamentary injections were given using an intraligamentary syringe with back-pressure after a failed primary inferior alveolar nerve block.
Interventions
Supplementary anesthetic injections after failed primary nerve block
Eligibility Criteria
You may qualify if:
- Symptomatic carious exposed mandibular first or second molars.
- Positive and prolonged response to thermal sensitivity tests and electric pulp tests.
- Vital coronal pulp on access cavity preparation.
- American Society of Anesthesiologists class I or II medical history.
- Ability to understand the use of pain scales.
You may not qualify if:
- Active pain in more than 1 tooth.
- Teeth with fused roots.
- Radiographic evidence of an extra root.
- Large restorations with overhanging margins.
- Full crowns or deep periodontal pockets.
- Known allergy or contraindications to any content of the local anesthetic solution or NSAIDs
- History of known or suspected drug abuse.
- Taking any drugs which could affect the pain perception, e.g, opiods, antidepressants, anticonvulsants, muscle relaxants, anxiolytics, sedatives, nsaids. 23
- Pregnant or breastfeeding patients.
- Patients with asthma, gastric ulcers, and bleeding disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Jamia MIliia Islamia
New Delhi, 110025, India
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 18, 2023
Study Start
July 5, 2023
Primary Completion
October 3, 2023
Study Completion
October 3, 2023
Last Updated
October 19, 2023
Record last verified: 2023-10